Jeff Keyser Email

Co-CEO, Co-Founder . Rénibus Therapeutics

Current Roles

Employees:
38
Revenue:
$3.8M
About
Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.
Rénibus Therapeutics Address
181 Grand Ave
Southlake, TX
Rénibus Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.